REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 172 filers reported holding REGENXBIO INC in Q2 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $716,668 | -22.1% | 43,540 | -5.4% | 0.00% | 0.0% |
| Q2 2023 | $919,900 | +2.9% | 46,018 | -2.6% | 0.00% | 0.0% |
| Q1 2023 | $893,687 | -17.8% | 47,260 | -1.5% | 0.00% | -50.0% |
| Q4 2022 | $1,087,642 | -13.2% | 47,956 | +1.2% | 0.00% | 0.0% |
| Q3 2022 | $1,253,000 | +5.1% | 47,408 | -1.8% | 0.00% | 0.0% |
| Q2 2022 | $1,192,000 | -18.9% | 48,263 | +9.0% | 0.00% | 0.0% |
| Q1 2022 | $1,469,000 | -7.0% | 44,269 | -8.3% | 0.00% | 0.0% |
| Q4 2021 | $1,579,000 | -20.5% | 48,296 | +1.9% | 0.00% | -33.3% |
| Q3 2021 | $1,986,000 | -6.1% | 47,386 | -12.9% | 0.00% | 0.0% |
| Q2 2021 | $2,115,000 | +6.3% | 54,434 | -6.7% | 0.00% | 0.0% |
| Q1 2021 | $1,990,000 | -14.7% | 58,343 | +13.4% | 0.00% | 0.0% |
| Q4 2020 | $2,334,000 | +64.8% | 51,457 | 0.0% | 0.00% | +50.0% |
| Q3 2020 | $1,416,000 | -24.5% | 51,457 | +1.1% | 0.00% | -33.3% |
| Q2 2020 | $1,875,000 | +14.8% | 50,903 | +1.0% | 0.00% | -25.0% |
| Q1 2020 | $1,633,000 | -21.4% | 50,418 | -0.6% | 0.00% | 0.0% |
| Q4 2019 | $2,078,000 | +12.2% | 50,718 | -2.5% | 0.00% | 0.0% |
| Q3 2019 | $1,852,000 | -29.8% | 52,018 | +1.2% | 0.00% | -20.0% |
| Q2 2019 | $2,640,000 | -6.2% | 51,396 | +4.6% | 0.01% | -16.7% |
| Q1 2019 | $2,815,000 | +33.7% | 49,118 | -2.2% | 0.01% | +20.0% |
| Q4 2018 | $2,106,000 | -42.4% | 50,210 | +3.6% | 0.01% | -28.6% |
| Q3 2018 | $3,658,000 | +16.5% | 48,448 | +10.7% | 0.01% | 0.0% |
| Q2 2018 | $3,139,000 | +148.3% | 43,747 | +3.3% | 0.01% | +133.3% |
| Q1 2018 | $1,264,000 | -12.3% | 42,353 | -2.4% | 0.00% | 0.0% |
| Q4 2017 | $1,442,000 | -0.6% | 43,382 | -1.5% | 0.00% | 0.0% |
| Q3 2017 | $1,451,000 | +50.7% | 44,022 | -9.7% | 0.00% | +50.0% |
| Q2 2017 | $963,000 | +25.1% | 48,775 | +22.3% | 0.00% | 0.0% |
| Q1 2017 | $770,000 | -0.6% | 39,875 | -4.5% | 0.00% | 0.0% |
| Q4 2016 | $775,000 | +29.4% | 41,775 | -2.3% | 0.00% | +100.0% |
| Q3 2016 | $599,000 | +76.2% | 42,775 | +0.7% | 0.00% | 0.0% |
| Q2 2016 | $340,000 | +102.4% | 42,475 | +173.3% | 0.00% | – |
| Q1 2016 | $168,000 | -24.7% | 15,540 | +15.5% | 0.00% | -100.0% |
| Q4 2015 | $223,000 | – | 13,450 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 831,014 | $15,714,475 | 6.51% |
| MPM BioImpact LLC | 617,671 | $11,680,159 | 3.03% |
| Sonic GP LLC | 193,079 | $3,651,124 | 2.79% |
| ArchPoint Investors | 224,278 | $4,241,097 | 1.84% |
| Redmile Group, LLC | 1,640,725 | $31,026,110 | 1.35% |
| MIRABELLA FINANCIAL SERVICES LLP | 25,983 | $5,461,344 | 0.83% |
| WS MANAGEMENT LLLP | 396,997 | $7,507,213 | 0.79% |
| Redwood Wealth Management Group, LLC | 15,190 | $287,243 | 0.33% |
| SummerHaven Investment Management, LLC | 27,503 | $520,082 | 0.30% |
| Lombard Odier Asset Management (Switzerland) SA | 130,369 | $2,465,278 | 0.22% |